KUALA LUMPUR: KPJ Healthcare Bhd
’s net profit fell 27% to RM18.46mil in the fourth quarter ended Dec 31, 2021, from RM26.28mil a 12 months prior.
The healthcare group recorded complete income of RM689.1mil in 4Q21, a rise of 11% in comparison with RM622.3mil in the earlier corresponding quarter.
During the quarter beneath evaluate, outpatient visits elevated to 730,992 from 707,177, whereas inpatient visits elevated to 71,007 from 57,722 in the earlier corresponding quarter.
It recorded complete earnings earlier than curiosity, depreciation and amortisation (Ebitda) of RM138.9mil, up 14% improve from RM121.7mil in the earlier corresponding quarter.
For the complete monetary 12 months ended Dec 31, 2021 (FY21), KPJ’s net profit greater than halved to RM51.03mil in opposition to RM110.44mil in FY20 whereas income rose 10% to RM2.62bil from RM2.39mil a 12 months prior.
KPJ mentioned the upper income was as a result of elevated actions all year long, together with higher collaboration with the general public healthcare sector to deal with Covid-19 sufferers, increased Covid-19 screening, laboratory testing, and vaccination companies.
The group recorded complete Ebitda of RM529.5mil in 2021, decrease by 2% from RM538.9mil in 2020.
Its pretax profit fell 23% to RM115.6mil in 202 from RM150.8mil 2020, primarily because of the improve in supplies price because of this of complying with the Covid-19 commonplace working process’s (SOP) requirement, utilization of private protecting tools (PPE) by our staff and obligatory requirement for RT-PCR check for all inpatients had resulted to increased working prices throughout this Covid -19 pandemic.
In addition, the group made a reversal of provisions in 2020 that was not repeated in 2021.
On its prospects, KPJ mentioned while the group continued to broaden its operation, it is usually anticipating that the challenges posed by the pandemic will proceed in the 12 months 2022.
“The group has identified key strategic focus areas for 2022 that will shape its ability to navigate from recovering to thriving in the post-pandemic ‘new normal’ and advance its journey in the industry.
“Our focus will continue to cover greater adoption of virtual health and other digital innovations, as well as public-private collaborations via decanting of non-Covid-19 cases in efforts to alleviate the strain on the public healthcare system,” it mentioned.
